SELLAS Life Sciences Group, Inc. (SLS)

11.74 +0.41 (+3.62%) USD  |  NASDAQ  |  Oct 02, 16:00
11.75 +0.01 (+0.09%) After-Hours: 20:00
More

SELLAS Life Sciences Group EPS LT Growth Estimates

EPS LT Growth Estimates Chart

View EPS LT Growth Estimates for SLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical EPS LT Growth Estimates Data

View and export this data back to . Start Trial.
Date Value

EPS LT Growth Estimates Range, Past 5 Years

View EPS LT Growth Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS LT Growth Estimates Benchmarks

View EPS LT Growth Estimates Benchmarks
Start Trial
AbbVie, Inc. Upgrade
Capricor Therapeutics, Inc. --
Alnylam Pharmaceuticals, Inc. --
Incyte Corp. Upgrade
Insmed, Inc. --